Lenz Arts in downtown Santa Cruz celebrates 57 years - Santa Cruz Sentinel
9 hours ago • Google News
LENZ Therapeutics Inc (LENZ)
US$ 35.22998.3%
Price Chart
Key Statistics
Market Cap
$ 976.39M
P/E Ratio
52.56
Revenue (TTM)
$ 0
Volume
192.06K
52W High
$ 38.93
52W Low
$ 16.54
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
29.4735
200-Day MA
27.55
52 Week High
38.93
52 Week Low
16.535
About LENZ
LENZ Therapeutics, Inc. operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.
Employees
N/A
Headquarters
Solana Beach, CA
CEO
Mr. Evert B. Schimmelpennink
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg